A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.
A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer. Am J Clin Oncol. 2009 Jun; 32(3):269-73.